Dear Editor, Varicella in healthcare workers (HCWs) is associated with morbidity, absenteeism and risk of transmission of disease to hospitalised patients. [1] Hence, immunisation of HCWs against varicella is a standard practice in the developed world. [1] In contrast, varicella immunisation in the Indian healthcare setup is not a routine practice. Studies on varicella immunogenicity report seronegativity in around 10%-15% of adults from India and other tropical Asian countries. [2] High seronegativity rates ranging from 25% to 70% have been reported in Indian HCWs. [3, 4] Kokilaben Dhirubhai Ambani Hospital is a 750-bedded tertiary-level hospital in Mumbai, India, commissioned in January 2009. In the end of 2011, 13 nurses residing in the nurse's hostel contracted chicken pox over a short span of 4 weeks. Hence, 2012 onwards, the hospital infection prevention and control committee started screening nurses with no history of chicken pox for anti-varicella immunoglobulin G (IgG). A total of 600 nurses were interviewed, of which 247 nurses were tested; 120 were seronegative and offered the vaccine. Despite this strategy, both outbreaks and sporadic cases continued to occur. Hence, 2014 onwards, it was decided to test all nurses irrespective of a history of chicken pox for anti-varicella IgG. Since the past 4 years (2014-2017), a total of 5000 nurses have been tested with anti-varicella IgG ELISA (Novatech, Germany), of which 1400 were seronegative (28%). Most of these nurses were in the age bracket of 21-30 years. Vaccination with two doses of the vaccine was offered to all seronegative nurses. Since then, a significant decline in chicken pox cases in nurses has been observed.
Our study highlights the need for varicella immunisation of Indian HCWs. The World Health Organization recommends that even those countries where varicella vaccine is not included in the usual immunisation schedule should consider vaccinating its susceptible HCWs against varicella, especially those in contact with immunocompromised and premature infants. [5] The recommended schedule is two doses of the varicella vaccine (0.5 ml) administered subcutaneously 4-8 weeks apart. However, the high cost of anti-varicella IgG/vaccine and rapid attrition of nursing staff are logistic problems that need attention.
Dear Editor, Congenital syphilis, an outcome of maternal syphilis, occurs either due to transplacental transmission of Treponema pallidum in utero or through contact with an infectious genital lesion during delivery. A severe and disabling infection, it is associated with miscarriage, stillbirths and neonatal deaths, foetal abnormalities and prematurity. [1] Live neonates develop either an early symptomatic disease or may be asymptomatic at birth developing serious sequelae later. In the recent years, due to improved medical care, congenital syphilis has become a comparative rarity. However, slight resurgence of the entity can be observed from time to time in both developed and newly industrialised countries. [2, 3] The disease still continues to affect pregnant women, resulting in considerable perinatal morbidity and mortality. Globally, just over 2 million pregnant women test positive for syphilis each year, comprising 1.5% of all pregnancies worldwide and resulting in 692,100-1.53 million adverse pregnancy outcomes including 650,000 perinatal deaths. [4, 5] Thus, despite the fact that congenital syphilis can be detected and treated successfully, it continues to be a serious healthcare problem, particularly in developing nations. We report here a case of congenital syphilis in a premature infant to highlight and emphasise the continuing scourge of this serious, yet preventable disease.
A male baby born by spontaneous vaginal delivery to a 33-year-old primigravida mother at 31 weeks of gestation with a birth weight of 1400 g presented on day 1 with respiratory distress and paucity of movements of all limbs. The baby was immediately admitted to the Neonatal Intensive Care Unit because of prematurity and respiratory distress. Born at a community health centre (CHC), the baby was referred to our hospital because of the onset of respiratory distress soon after birth, which could not be managed at the CHC.
The infant's vital signs on admission were as follows: Temperature 33.9°C, heart rate 120/min, respiratory rate 66/min and SpO 2 38%. On physical examination, the baby appeared cyanotic and limp, with a capillary refill time of 3 s and had shallow respiratory efforts. There were no other relevant positive clinical findings. Hence, immediately, the baby was put on nasal continuous positive airway pressure (CPAP) support. Complete blood count of the baby including haemoglobin (131 g/L), platelet count (2.4 × 10 9 /L) and red cell count (4.4 × 10 6 /L) were within normal limits, except for the white blood cell count that showed leucocytosis (20.3 × 10 9 /L with 68% neutrophils, 26% lymphocytes and 4% monocytes). Random blood sugar level (54 mg/dL) was normal. On further examination, sepsis screen was found to be negative. Long bone radiography revealed no bony changes. However, chest X-ray revealed fluid in interlobar fissure (right) and streaky opacities radiating from hilum, suggestive of transient tachypnoea of the newborn. It was found that the mother had attended CHC for antenatal care (ANC) irregularly and she reported an uneventful antenatal period. However, no serological screening reports were available. Hence, as part of routine protocol, maternal samples were sent for serology. Tests for human immunodeficiency virus (HIV) and hepatitis B were non-reactive, but rapid plasma reagin (RPR) (Beacon Diagnostics Pvt. Ltd., Navsari, India) test was reactive at a dilution of 1:8 [ Figure 1a ]. Hence, blood sample from the baby was also sent for relevant investigations which showed toxoplasma immunoglobulin M to be negative and tests for HIV and hepatitis B to be non-reactive. However, RPR was reactive for the infant at a dilution of 1:16 [ Figure 1b ]. The father also had reactive RPR test at a dilution of 1:8 without clinical manifestations of syphilis. The T. pallidum haemagglutination test was positive in the baby, mother and
